Summary
- Current Price
- As of today, CUE price is $27.66, up +23.87% on
- Current Price All-Time High
- CUE price is currently -97.09% below its historical high of $950.70 set on
- Market Cap
- CUE current market cap is $201M, up +178.98% over the past 365 days
- Revenue
- CUE current annual revenue is $27.47M, up +195.75% year-over-year
- Next Earnings
- As of today, the next earnings release for CUE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cue Biopharma, Inc. |
| Ticker | NASDAQ: CUE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cuebiopharma.com |
| Employees | 41 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $27.66 | ||
| Price, 1D Change | +23.87% | |
| $201M | ||
| - | ||
| - | ||
| 2.77 | ||
| $27.47M | ||
| Revenue, 1Y Change | +195.75% | |
| -$8.42 | ||
| EPS, 1Y Change | +61.11% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$8.42 | ||
| EPS Estimate | -$25.01 | N/A |
| EPS Est. Change | -196.88% | N/A |
| $27.47M | ||
| Revenue Estimate | $15.62M | N/A |
| Revenue Est. Change | -43.13% | N/A |
| $27.66 | ||
| Price Target | $83.00 | - |
| Price Tgt. Change | +200.07% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.76 | -$21.66 | -2,769.23% | |
| -$0.40 | -$8.42 | -2,006.08% | |
| -$25.01 | N/A | -196.88% | |
| -$7.44 | N/A | +11.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.41M | $9.29M | -1.31% | |
| $6.50M | $27.47M | +322.55% | |
| $15.62M | N/A | -43.13% | |
| $8.65M | N/A | -68.49% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -0.43% | ||
| -54.80% | ||
| +178.98% | ||
| -92.72% | ||
| +195.75% | ||
| +2,105.75% | ||
| +61.11% | ||
| -466.53% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $27.66 | ||
| $20.45 | ||
| $28.07 | ||
| $24.37 | ||
| $27.94 | ||
| -$1.44 | ||
| 2.77 | ||
| $3.65 | ||
| 50.37 | ||
| 152.99% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $27.47M | ||
| -$8.42 | ||
| $23.99M | ||
| 98.73% | ||
| -$26.52M | ||
| -96.56% | ||
| -$26.60M | ||
| -96.85% | ||
| -$23.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.16 | ||
| 2.74 | ||
| 2.74 | ||
| - | ||
| 4 | ||
| -5.48 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 5.34 | ||
| 86.98 | ||
| -1.96 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $26.43M | ||
| $27.14M | ||
| $43.15M | ||
| $36.98M | ||
| $16.71M | ||
| $13.49M | ||
| $4.20M | ||
| $1.91M | ||
| $3.95M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $54.07M | ||
| $50.51M | ||
| $347.70K | ||
| $0.00 | ||
| $3.48M | ||
| $0.00 | ||
| $500.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$21.69M | ||
| $75.00K | ||
| $26.29M | ||
| $177.00K | ||
| -$21.86M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| B. Riley Securities | ||
| LUCID CAPITAL MARKETS | ||
| Citizens Capital Markets | → | |
| Stifel | → | |
| Piper Sandler | → | |
| JMP Securities | → | |
| Stifel | → | |
| Oppenheimer | → | |
| Piper Sandler | → | |
| Jefferies |
Analyst sentiment
Institutional ownership
Screeners with CUE
FAQ
- What is the ticker symbol for Cue Biopharma, Inc.?
- The ticker symbol for Cue Biopharma, Inc. is NASDAQ:CUE
- Does Cue Biopharma, Inc. pay dividends?
- No, Cue Biopharma, Inc. does not pay dividends
- What sector is Cue Biopharma, Inc. in?
- Cue Biopharma, Inc. is in the Healthcare sector
- What industry is Cue Biopharma, Inc. in?
- Cue Biopharma, Inc. is in the Biotechnology industry
- What country is Cue Biopharma, Inc. based in?
- Cue Biopharma, Inc. is headquartered in United States
- When did Cue Biopharma, Inc. go public?
- Cue Biopharma, Inc. initial public offering (IPO) was on January 2, 2018
- Is Cue Biopharma, Inc. in the S&P 500?
- No, Cue Biopharma, Inc. is not included in the S&P 500 index
- Is Cue Biopharma, Inc. in the NASDAQ 100?
- No, Cue Biopharma, Inc. is not included in the NASDAQ 100 index
- Is Cue Biopharma, Inc. in the Dow Jones?
- No, Cue Biopharma, Inc. is not included in the Dow Jones index
- When was Cue Biopharma, Inc. last earnings report?
- Cue Biopharma, Inc.'s most recent earnings report was on May 15, 2025
- When does Cue Biopharma, Inc. report earnings?
- The date for Cue Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CUE Official Website www.cuebiopharma.com
- CUE Profile on Yahoo Finance finance.yahoo.com/quote/CUE
- CUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cue
